Skip to content

Study · Not a test of the peptide alone · 2020

1 result

Trastuzumab-Induced Severe Thrombocytopenia:A Case Report and Literature Review.

Zeng XQ, Jiang SS, Peng YY, Liu MF, Ye CS, Dong JY

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih1 Dec 2020Cited by 3 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01HumanNot a test of Oxytocin aloneCase report or seriesEfficacy outcome

    In a woman with trastuzumab-induced severe thrombocytopenia, a regimen of platelet transfusions, glucocorticoids, oxytocin and thrombopoietic drugs was followed by complete platelet recovery in 11 days.

    In plain wordsIn one woman with a severe drop in platelets, a mix of treatments including oxytocin was followed by full recovery in 11 days.

    Peptide
    Oxytocin
    Outcome
    IncreasePlatelet count recovery after combined treatment
    Study

    n = 1

    Outcome group
    Bleeding and clotting · Whole body

    Source sentences

    Summary
    With the treatment of single-donor platelet transfusions, glucocorticoids, oxytocin and thrombopoietic drugs, the platelet count recovered completely in 11 days.
    1 context sentence
    Summary · context
    The patient developed trastuzumab-induced thrombocytopenia in 6 hours after an intravenous infusion of trastuzumab at the second cycle of trastuzumab treatment with the symptom of abnormal uterine bleeding.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:49 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.